ANDA 220012, held by Macleods Pharms. Colestipol Hydrochloride.
As of Nov 16, 2026, ANDA 220012 (Colestipol Hydrochloride), held by Macleods Pharms, was first approved by FDA on Sep 15, 2025, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 15, 2025 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Colestipol Hydrochloride1GM ยท tablet;oral | Colestipol Hydrochloride | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters